GLP-1

Class of medicines that imitate the action of an intestinal hormone regulating appetite and promoting weight loss; Wegovy is described as the first GLP-1 obesity treatment marketed in France in oral form.

Why Someone Else’s Weight Loss Can Trigger Body Insecurities
Study links GLP-1 drug use to changes in food spending
Wegovy Pill Arrives in French Pharmacies as Obesity Drug Competition Heats Up